Publications by authors named "Alison Weppler"

Claim this Profile
P
Patient and population impacts of multi-gene panel and pembrolizumab coverage in metastatic melanoma.
Deirdre Weymann, Emanuel Krebs, Samantha Pollard, Melanie Mcphail, Ian Bosdet, Alison M Weppler

J Natl Cancer Inst· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation.
Emanuel Krebs, Deirdre Weymann, Cheryl Ho, Alison Weppler, Ian Bosdet

JCO Precis Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation.
Emanuel Krebs, Deirdre Weymann, Cheryl Ho, Alison Weppler, Ian Bosdet

JCO Precis Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients.
Yinghong Wang, Hamzah Abu-Sbeih, Tenglong Tang, Malek Shatila, David Faleck, Alison M Weppler

Gastrointest Endosc· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis.
Anna Galligan, Amir Iravani, Arian Lasocki, Roslyn Wallace, Alison M Weppler

Front Endocrinol (Lausanne)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG PET/CT Prognostic Markers in Patients with Advanced Melanoma Treated with Ipilimumab and Nivolumab.
Amir Iravani, Roslyn Wallace, Serigne N Lo, Anna Galligan, Alison M Weppler

Radiology· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation.
Alison M Weppler, Laetitia Da Meda, Ines Pires da Silva, Wen Xu, Giovanni Grignani

Eur J Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment.
Angela Pizzolla, Simon Paul Keam, Ismael A Vergara, Franco Caramia, Niko Thio, Alison Weppler

J Immunother Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES).
Peter Kar Han Lau, Breon Feran, Lorey Smith, Arian Lasocki, Ramyar Molania, Alison Weppler

J Immunother Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis.
Anne Zaremba, Rafaela Kramer, Viola De Temple, Stefanie Bertram, Martin Salzmann, Alison M Weppler

Front Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysis.
Judith M Versluis, Anne M Hendriks, Alison M Weppler, Lauren J Brown, Karlijn de Joode

Eur J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival.
Nicholas A Gherardin, Kelly Waldeck, Alex Caneborg, Luciano G Martelotto, Shiva Balachander, Alison M Weppler

Cancer Immunol Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study.
Ines Pires da Silva, Tasnia Ahmed, Irene L M Reijers, Alison M Weppler, Allison Betof Warner

Lancet Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders.
Lauren J Brown, Alison Weppler, Prachi Bhave, Clara Allayous, J Randall Patrinely

J Immunother Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematological immune related adverse events after treatment with immune checkpoint inhibitors.
Rafaela Kramer, Anne Zaremba, Alvaro Moreira, Selma Ugurel, Douglas B Johnson, Alison Weppler

Eur J Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment.
Amir Iravani, Medhat M Osman, Alison M Weppler, Roslyn Wallace, Anna Galligan

Eur J Nucl Med Mol Imaging· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refusal of colorectal cancer surgery in the United States: Predictors and associated cancer-specific mortality in a Surveillance, Epidemiology, and End Results (SEER) cohort.
Megan Delisle, Shubhi Singh, Jeffrey Howard, Nikhil Panda, Alison M Weppler

Surg Open Sci· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma.
Alison M Weppler, Andrew Pattison, Prachi Bhave, Paolo De Ieso, Jeanette Raleigh

J Immunother Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors.
Jenny H Lee, Alexander M Menzies, Matteo S Carlino, Ashleigh C McEvoy, Shahneen Sandhu, Alison M Weppler

Clin Cancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies.
Christina W Guo, Marliese Alexander, Youseph Dib, Peter K H Lau, Alison M Weppler

Eur J Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency medicine ultrasonography in rural communities.
Candi J Flynn, Alison Weppler, Daniel Theodoro, Elizabeth Haney, W Ken Milne

Can J Rural Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis